Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v4-EN
Language French English
Date Updated 2020-05-29 2020-04-20
Drug Identification Number 02454599 02454599
Brand name PHENYLEPHRINE HYDROCHLORIDE INJECTION PHENYLEPHRINE HYDROCHLORIDE INJECTION
Common or Proper name phenylephrine hydrochloride injection phenylephrine hydrochloride injection
Company Name LABORATOIRE AGUETTANT LABORATOIRE AGUETTANT
Ingredients PHENYLEPHRINE HYDROCHLORIDE PHENYLEPHRINE HYDROCHLORIDE
Strength(s) 50MCG 50MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 syringes per box 10 syringes per box
ATC code C01CA C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-05-02 2020-04-25
Actual start date
Estimated end date 2020-05-29 Unknown
Actual end date 2020-05-28
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments COVID 19 has caused unprecedented drug demand and a potential risk of drug shortage COVID 19 has caused unprecedented drug demand and a potential risk of drug shortage
Health Canada comments